PL3418273T3 - Pochodne flawaglin - Google Patents
Pochodne flawaglinInfo
- Publication number
- PL3418273T3 PL3418273T3 PL18187037.9T PL18187037T PL3418273T3 PL 3418273 T3 PL3418273 T3 PL 3418273T3 PL 18187037 T PL18187037 T PL 18187037T PL 3418273 T3 PL3418273 T3 PL 3418273T3
- Authority
- PL
- Poland
- Prior art keywords
- flavagline derivatives
- flavagline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1456474A FR3023290B1 (fr) | 2014-07-04 | 2014-07-04 | Derives de flavaglines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3418273T3 true PL3418273T3 (pl) | 2022-08-01 |
Family
ID=52016681
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18187037.9T PL3418273T3 (pl) | 2014-07-04 | 2015-07-06 | Pochodne flawaglin |
| PL15733767T PL3164393T3 (pl) | 2014-07-04 | 2015-07-06 | Pochodne flawaglin |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15733767T PL3164393T3 (pl) | 2014-07-04 | 2015-07-06 | Pochodne flawaglin |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10047064B2 (enExample) |
| EP (3) | EP3418273B1 (enExample) |
| JP (4) | JP6637954B2 (enExample) |
| DK (2) | DK3164393T3 (enExample) |
| ES (2) | ES2908225T3 (enExample) |
| FR (1) | FR3023290B1 (enExample) |
| PL (2) | PL3418273T3 (enExample) |
| TR (1) | TR201819805T4 (enExample) |
| WO (1) | WO2016001441A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3023290B1 (fr) * | 2014-07-04 | 2016-08-19 | Pf Medicament | Derives de flavaglines |
| DK3888658T3 (da) | 2015-11-25 | 2024-03-18 | Effector Therapeutics Inc | Eif4-a-inhiberende forbindelser og fremgangsmåder relateret dertil |
| DK3643707T3 (da) * | 2017-06-19 | 2022-05-09 | Futurechem Co Ltd | 18f-mærket forbindelse til diagnosticering af prostatkræft, og anvendelse deraf |
| KR20200123184A (ko) * | 2018-02-19 | 2020-10-28 | 메모리얼 슬로안 케터링 캔서 센터 | 증식이상 장애를 치료하기 위한 물질 및 방법 |
| CA3095515A1 (en) | 2018-04-10 | 2019-10-17 | Cellectar Biosciences, Inc. | Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy |
| EP3863625A4 (en) * | 2018-10-09 | 2022-06-29 | The Research Institute at Nationwide Children's Hospital | Anticancer rocaglamide derivatives |
| WO2020086562A1 (en) * | 2018-10-22 | 2020-04-30 | Trustees Of Boston University | Compositions and methods for inhibiting viral infection |
| BR112022006739B1 (pt) | 2019-10-10 | 2024-01-23 | Cellectar Biosciences, Inc | Conjugados fosfolipídio-flavagina e métodos de uso do mesmo para terapia direcionada a câncer |
| WO2025104293A1 (en) * | 2023-11-17 | 2025-05-22 | Gustave Roussy Transfert | Inhibitors of eif4a and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ866500A0 (en) * | 2000-07-05 | 2000-08-03 | Exgenix Operations Pty Ltd | Therapeutic compounds and methods |
| DE102004024504A1 (de) * | 2004-05-18 | 2006-02-16 | Bayer Healthcare Ag | Neue Cylopenta[b]benzofuran-Derivate und ihre Verwendung |
| US8137509B2 (en) * | 2006-05-22 | 2012-03-20 | Trustees Of Boston University | Asymmetric synthesis of rocaglamides via enantioselective photocycloaddition mediated by chiral brønsted acids |
| EP2189453A1 (en) * | 2008-11-25 | 2010-05-26 | Université Louis Pasteur | Rocaglaol derivatives as cardioprotectant agents |
| MX2011005482A (es) | 2008-12-05 | 2011-06-16 | Intermed Discovery Gmbh | Inhibidores de acumulacion de la proteina del factor 1 inducible por hipoxia. |
| FR3023290B1 (fr) * | 2014-07-04 | 2016-08-19 | Pf Medicament | Derives de flavaglines |
-
2014
- 2014-07-04 FR FR1456474A patent/FR3023290B1/fr active Active
-
2015
- 2015-07-06 DK DK15733767.6T patent/DK3164393T3/en active
- 2015-07-06 WO PCT/EP2015/065294 patent/WO2016001441A1/fr not_active Ceased
- 2015-07-06 DK DK18187037.9T patent/DK3418273T3/da active
- 2015-07-06 US US15/323,650 patent/US10047064B2/en active Active
- 2015-07-06 ES ES18187037T patent/ES2908225T3/es active Active
- 2015-07-06 PL PL18187037.9T patent/PL3418273T3/pl unknown
- 2015-07-06 ES ES15733767T patent/ES2700156T3/es active Active
- 2015-07-06 EP EP18187037.9A patent/EP3418273B1/fr active Active
- 2015-07-06 JP JP2017500083A patent/JP6637954B2/ja active Active
- 2015-07-06 PL PL15733767T patent/PL3164393T3/pl unknown
- 2015-07-06 EP EP21213303.7A patent/EP3998257A1/fr active Pending
- 2015-07-06 EP EP15733767.6A patent/EP3164393B1/fr active Active
- 2015-07-06 TR TR2018/19805T patent/TR201819805T4/tr unknown
-
2017
- 2017-12-01 US US15/829,630 patent/US10519125B2/en active Active
-
2019
- 2019-12-20 JP JP2019230768A patent/JP6951406B2/ja active Active
-
2021
- 2021-09-22 JP JP2021154798A patent/JP7340574B2/ja active Active
-
2023
- 2023-08-25 JP JP2023137552A patent/JP2023159393A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3164393A1 (fr) | 2017-05-10 |
| WO2016001441A1 (fr) | 2016-01-07 |
| JP2022000455A (ja) | 2022-01-04 |
| ES2908225T3 (es) | 2022-04-28 |
| DK3418273T3 (da) | 2022-03-21 |
| PL3164393T3 (pl) | 2019-03-29 |
| JP2020063289A (ja) | 2020-04-23 |
| US20180086729A1 (en) | 2018-03-29 |
| US10519125B2 (en) | 2019-12-31 |
| US20170137400A1 (en) | 2017-05-18 |
| US10047064B2 (en) | 2018-08-14 |
| EP3418273A1 (fr) | 2018-12-26 |
| JP6637954B2 (ja) | 2020-01-29 |
| TR201819805T4 (tr) | 2019-01-21 |
| ES2700156T3 (es) | 2019-02-14 |
| EP3998257A1 (fr) | 2022-05-18 |
| JP2023159393A (ja) | 2023-10-31 |
| EP3418273B1 (fr) | 2022-01-12 |
| JP2017519796A (ja) | 2017-07-20 |
| JP7340574B2 (ja) | 2023-09-07 |
| EP3164393B1 (fr) | 2018-09-19 |
| DK3164393T3 (en) | 2019-01-21 |
| FR3023290B1 (fr) | 2016-08-19 |
| JP6951406B2 (ja) | 2021-10-20 |
| FR3023290A1 (fr) | 2016-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3236972T3 (en) | Antivirale N4-hydroxycytidin-derivativer | |
| IL253381B (en) | History of h9–pyrrolo–dipyridine | |
| ZA201704602B (en) | Dihydroindolizinone derivative | |
| SG11201609205WA (en) | Heterocyclyl-butanamide derivatives | |
| PL3164393T3 (pl) | Pochodne flawaglin | |
| HUE050450T2 (hu) | Fluoralkil-fluorén-származékok | |
| IL248773A0 (en) | History of naphthyridinedione | |
| DK3191586T3 (en) | Cellobiosephosphorylase | |
| IL251005B (en) | Pyrido-oxazinone derivatives | |
| AP2016009530A0 (en) | Cycloalkyl-linked diheterocycle derivatives | |
| PL3119744T3 (pl) | Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu | |
| PL3097076T3 (pl) | Nowe pochodne CYP-eikozanoidowe | |
| IL248772A0 (en) | A consequence of cyclohexyl pyridine | |
| GB201401268D0 (en) | TrackPack | |
| AU5594P (en) | Lanoregon Mandevilla sanderi | |
| AU5597P (en) | Lancalifornia Mandevilla sanderi | |
| AU5583P (en) | Lanminnesota Mandevilla sanderi | |
| AU5285P (en) | FLOMANRER Mandevilla sanderi | |
| AU2014264V (en) | FlatGL Templetonia retusa | |
| AP00672S1 (en) | Tabacchiera | |
| GB201406611D0 (en) | Buildpath | |
| GB201406027D0 (en) | Hwbh-2 | |
| GB201405392D0 (en) | Sonarpill | |
| GB201405373D0 (en) | Bedaloo/portloo/bedaloo | |
| GB201404931D0 (en) | Necktunes |